0 0 -0.00252360623330737 -0.00229227566192083 0 -0.00128283316859784 0.000189270467498122 -0.000567811402494126
Sign Up Today X
Thanks for submitting the form.
Stockreport

Vertex Insider Sales Versus Valuation Gap Raise Investor Questions [Yahoo! Finance]

Vertex Pharmaceuticals Incorporated (VRTX)  More Company Research Source: Yahoo! Finance
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Vertex Pharmaceuticals (NasdaqGS:VRTX) executives, including the CEO and CMO, recently sold company stock under pre-approved Rule 10b5-1 trading plans. The transactions involved planned share sales executed over a defined period, as disclosed in regulatory filings. The activity represents a material insider trading event because it involves multiple top leaders and has been formally reported to investors. Vertex focuses on treatments for serious diseases, with an established presence in cystic fibrosis therapies and work in other areas such as pain and gene editing partnerships. For investors, it sits in a group of large biopharma names where pipelines, regulatory milestones, and patent timelines often carry as much weight as current product revenues. Insider sales under Rule 10b5-1 plans are designed to separate personal trading decisions from day to day corporate de [Read more]
IMPACT SNAPSHOT EVENT TIME: VRTX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
VRTX alerts
from News Quantified
VRTX
NEWS
VRTX
Earnings
VRTX
Analyst Actions
VRTX
SEC Filings
Stockreport

Vertex Insider Sales Versus Valuation Gap Raise Investor Questions [Yahoo! Finance]

Vertex Pharmaceuticals Incorporated  (VRTX) 
More Company Research Source: Yahoo! Finance
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Vertex Pharmaceuticals (NasdaqGS:VRTX) executives, including the CEO and CMO, recently sold company stock under pre-approved Rule 10b5-1 trading plans. The transactions involved planned share sales executed over a defined period, as disclosed in regulatory filings. The activity represents a material insider trading event because it involves multiple top leaders and has been formally reported to investors. Vertex focuses on treatments for serious diseases, with an established presence in cystic fibrosis therapies and work in other areas such as pain and gene editing partnerships. For investors, it sits in a group of large biopharma names where pipelines, regulatory milestones, and patent timelines often carry as much weight as current product revenues. Insider sales under Rule 10b5-1 plans are designed to separate personal trading decisions from day to day corporate de [Read more]
IMPACT SNAPSHOT
EVENT TIME:
VRTX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS